https://mdtechcouncil.com/maryland-tech-council-announces-2024-icon-award-finalists/
$3.7 Million SBIR Ph 2 grant from the NIDDK (NIH)
GlycoMantra has been awarded a two-year SBIR Phase 2 grant ($3.7 M) from the NIDDK (NIH) for the commercial development of the GlycoMantra drug product.
